Multicenter observational study of the efficacy of sitagliptin in patients at high risk of cardiovascular disease.

Trial Profile

Multicenter observational study of the efficacy of sitagliptin in patients at high risk of cardiovascular disease.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 May 2016

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 Jul 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 11 Jun 2011 Planned end date (Jul 2013) added as reported by University Hospital Medical Information Network - Japan.
    • 03 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top